Outcome of Board Meeting held on May 30, 2025

Revenue growth above 20%Net loss reportedNegative operating cash flowResults View source PDF Explain this filing

Price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close

+4.1%Reaction day

₹950.00

prior close

—

announcement price

After-mkt

timing

Nifty Microcap 250market · in no size index; the smallest one is used+0.1%+4.0% vs market

Diversified Commercial Services peers, median of 66sector+0.0%+4.1% vs sector

On the reaction day the stock moved 4.0 pts more than Nifty Microcap 250 and 4.1 pts more than its Diversified Commercial Services peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.

Minutes after the announcementfrom the announcement price · no benchmark

Stock

—

10m

—

15m

—

30m

—

Sessions after the filingfrom the prior close

StockMarketvs marketSectorvs sector

Reaction day

+4.1+0.1+4.0+0.0+4.1

Next day

+9.1-0.2+9.3-0.1+9.2

+9.3+0.3+9.0-0.5+9.8

+7.3+0.9+6.4+0.0+7.3

+8.4+0.8+7.6+0.1+8.3

+8.4+2.2+6.2+1.2+7.1

+7.9+3.4+4.5+1.2+6.7

15d

+5.8-0.8+6.6-0.9+6.6

+1.0+2.9-1.9-1.9+3.0

+2.6+0.8+1.8-6.4+9.1

—+0.0—-7.0—

UpDownMarket · Nifty Microcap 250Sector · Diversified Commercial Services peers, median of 66Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

The board approved standalone and consolidated audited financial results for Q4 and FY ended March 31, 2025, with the auditor issuing an unmodified (clean) opinion on both. Standalone revenue from operations nearly doubled to Rs. 2,759.27 lakhs (vs Rs. 1,405.78 lakhs in FY24), and standalone net profit more than doubled to Rs. 166.39 lakhs (vs Rs. 74.45 lakhs), with EPS rising to Rs. 8.98. Consolidated revenue grew strongly to Rs. 3,270.29 lakhs, but consolidated net profit declined to Rs. 75.07 lakhs (vs Rs. 106.49 lakhs) due to a Rs. 38.84 lakh loss share from associate Neuro and Spine Associates. Q4 standalone net profit fell sharply to Rs. 5.06 lakhs and consolidated Q4 swung to a loss of Rs. 61.52 lakhs. Both standalone and consolidated operating cash flows remained negative at Rs. (35.07) lakhs and Rs. (113.05) lakhs respectively.

Likely market impact

Strong topline growth and clean audit opinion are positives, but the sharp Q4 profit drop, consolidated FY PAT decline, and continued negative operating cash flows raise concerns about earnings quality and the drag from the associate investment. Shareholders should watch for sustained improvement in cash generation and consolidation outcomes.